A New Way to Diagnose Painful 'Wear-and-Tear' Arthritis?
By Dennis Thompson HealthDay Reporter
THURSDAY, Dec. 19, 2024 -- Knee arthritis could become easier to detect and diagnose thanks to a new test involving the lubricating fluid inside the joint.
A new study shows that arthritis of the knee often is diagnosed in its late stages, after cartilage has degraded and bones are rubbing against each other in the joint.
At that point, it’s tough to tell whether knee arthritis has been caused by natural wear and tear, or if an inflammatory disease is behind a person’s joint problems, the researchers noted in a new study published Dec. 18 in the Journal of Orthopaedic Research.
But a new test involving two markers found in the synovial fluid of patients’ joints might be able to help docs suss all this out more promptly.
The test “addresses an unmet need for objective diagnosis of osteoarthritis to improve clinical decision-making and patient outcomes,” researcher Daniel Keter with CD Diagnostics, a division of Zimmer Biomet, said in a journal news release.
The fluid test looks for a protein called cartilage oligomeric matrix protein (COMP), as well as an inflammatory biochemical called interleukin-8 (IL-8), researchers said.
COMP levels tend to be high in the synovial fluid of people with “wear-and-tear” osteoarthritis, because it’s released as cartilage breaks down.
On the other hand, IL-8 is low in osteoarthritis but elevated in people with inflammatory conditions like rheumatoid arthritis.
Using these two markers, researchers were able to accurately diagnose “wear-and-tear” osteoarthritis about 87% of the time in 171 knee synovial fluid specimens.
Up to 15% of U.S. adults 60 and older suffer from osteoarthritis, and it’s expected to become even more prevalent due to the aging population and the increase in risk factors like obesity, researchers noted.
A test like this could help steer people to the best arthritis treatment for them, and do so in a more timely way.
“Differentiating primary osteoarthritis from other inflammatory arthritis types contributes towards better diagnosis that enables accurate and targeted treatment of primary osteoarthritis,” the research team concluded.
However, they added that more research is needed to validate the test before it’s ready to be widely used.
Sources
- Wiley, news release, Dec. 18, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Body Mass Index (BMI): What It Tells You — And What It Doesn’t
SUNDAY, May 4, 2025 — Body Mass Index, or BMI, is a number that reflects the relationship between your height and weight. It's widely used in healthcare and public health to...
What You Should Know About ALS, Also Known as Lou Gehrig’s Disease
SATURDAY, May 3, 2025 — Amyotrophic lateral sclerosis (ALS) – known as Lou Gehrig’s Disease based on the iconic 1930s New York Yankee baseball player – is...
HHS, NIH Unveil Vaccine Initiative to Protect Against Future Pandemics
FRIDAY, May 2, 2025 -- The U.S. Department of Health and Human Services and the National Institutes of Health announced a new initiative called "Generation Gold Standard" to...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.